Innospec Inc. (NASDAQ:IOSP) SVP Hardy Louis Griffin III Sells 525 Shares

Innospec Inc. (NASDAQ:IOSP) SVP Hardy Louis Griffin III sold 525 shares of the business’s stock in a transaction on Monday, May 20th. The shares were sold at an average price of $129.78, for a total value of $68,134.50. Following the completion of the sale, the senior vice president now owns 4,523 shares in the company, valued at $586,994.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Hardy Louis Griffin III also recently made the following trade(s):

• On Thursday, February 22nd, Hardy Louis Griffin III sold 1,875 shares of Innospec stock. The shares were sold at an average price of $122.07, for a total value of $228,881.25.

Innospec Trading Down 0.2 %

IOSP opened at $130.12 on Thursday. The stock has a 50-day moving average price of $125.03 and a 200-day moving average price of $119.54. Innospec Inc. has a 12-month low of $91.74 and a 12-month high of $133.71. The stock has a market capitalization of $3.24 billion, a P/E ratio of 22.09 and a beta of 1.11.

Innospec (NASDAQ:IOSP) last issued its earnings results on Thursday, May 9th. The specialty chemicals company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.11. The company had revenue of $500.20 million during the quarter, compared to analysts’ expectations of $508.15 million. Innospec had a return on equity of 14.22% and a net margin of 7.60%. On average, equities research analysts predict that Innospec Inc. will post 6.7 EPS for the current year.

Innospec Dividend Announcement

The firm also recently declared a Semi-Annual dividend, which will be paid on Friday, May 31st. Shareholders of record on Monday, May 20th will be given a dividend of $0.72 per share. This represents a yield of 1.2%. The ex-dividend date is Friday, May 17th. Innospec’s payout ratio is 25.81%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of IOSP. Gendell Jeffrey L bought a new position in Innospec during the 1st quarter valued at approximately $7,090,000. Price T Rowe Associates Inc. MD increased its position in Innospec by 5.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,228 shares of the specialty chemicals company’s stock valued at $2,222,000 after buying an additional 916 shares in the last quarter. EntryPoint Capital LLC bought a new position in Innospec during the 1st quarter valued at approximately $147,000. CANADA LIFE ASSURANCE Co increased its position in Innospec by 6.7% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 29,888 shares of the specialty chemicals company’s stock valued at $3,846,000 after buying an additional 1,864 shares in the last quarter. Finally, Bessemer Group Inc. increased its position in Innospec by 3.2% during the 1st quarter. Bessemer Group Inc. now owns 121,921 shares of the specialty chemicals company’s stock valued at $15,720,000 after buying an additional 3,775 shares in the last quarter. Institutional investors own 96.64% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Innospec from a “buy” rating to a “strong-buy” rating in a research report on Friday, May 10th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.